CME/CE

Faculty: Barbara O'Brien, MD Faculty: Nadia Harbeck, MD, PhD What are the key considerations when managing brain metastases in patients with breast and lung cancer? This online CME activity uses case-based discussion to examine the epidemiology and clinical burden of central nervous system (CNS) involvement and how brain metastases influence prognosis, therapeutic priorities, and treatment se...

Faculty: Barbara O'Brien. MD What are the key considerations when managing brain metastases in patients with breast and lung cancer? This online CME activity uses case-based discussion to examine the epidemiology and clinical burden of central nervous system (CNS) involvement and how brain metastases influence prognosis, therapeutic priorities, and treatment sequencing. Participants will eval...

Host: Carole Bitar, MD, FAAD Guest: Matthew P. Giannetti, MD Guest: Benjamin Ungar, MD On-demand webcast featuring best practices for assessing and diagnosing patients with systemic mastocytosis, the latest data on new and emerging therapies, and strategies for providing patient-centered care.

Host: Sandhya Khurana, MD, FCCP Guest: Syed Shahzad Mustafa, MD Guest: Ashley Wilk, DO, DipABLM Part of the educational program Bridging Specialties ®: Timely Diagnosis and Treatment for Refractory Chronic Cough , this activity examines the diagnostic challenges associated with refractory chronic cough (RCC) and the importance of coordinated, guideline-directed evaluation across specialties. RCC i...

Faculty: Benjamin Levy, MD What are the key considerations when managing brain metastases in patients with breast and lung cancer? This online CME activity uses case-based discussion to examine the epidemiology and clinical burden of central nervous system (CNS) involvement and how brain metastases influence prognosis, therapeutic priorities, and treatment sequencing. Participants will evaluate em...

Faculty: Benjamin Levy, MD Faculty: Melin Khandekar, MD, PhD What are the key considerations when managing brain metastases in patients with breast and lung cancer? This online CME activity uses case-based discussion to examine the epidemiology and clinical burden of central nervous system (CNS) involvement and how brain metastases influence prognosis, therapeutic priorities, and treatment sequenc...

Faculty: Benjamin Levy, MD Faculty: Melin Khandekar, MD, PhD What are the key considerations when managing brain metastases in patients with breast and lung cancer? This online CME activity uses case-based discussion to examine the epidemiology and clinical burden of central nervous system (CNS) involvement and how brain metastases influence prognosis, therapeutic priorities, and treatment sequenc...

Faculty: Barbara O'Brien, MD Faculty: Nadia Harbeck, MD, PhD What are the key considerations when managing brain metastases in patients with breast and lung cancer? This online CME activity uses case-based discussion to examine the epidemiology and clinical burden of central nervous system (CNS) involvement and how brain metastases influence prognosis, therapeutic priorities, and treatment se...

Faculty: Barbara O'Brien, MD Faculty: Nadia Harbeck, MD, PhD What are the key considerations when managing brain metastases in patients with breast and lung cancer? This online CME activity uses case-based discussion to examine the epidemiology and clinical burden of central nervous system (CNS) involvement and how brain metastases influence prognosis, therapeutic priorities, and treatment se...

Faculty: Barbara O'Brien. MD What are the key considerations when managing brain metastases in patients with breast and lung cancer? This online CME activity uses case-based discussion to examine the epidemiology and clinical burden of central nervous system (CNS) involvement and how brain metastases influence prognosis, therapeutic priorities, and treatment sequencing. Participants will eval...

Faculty: Carol Wysham, MD Faculty: Samuel Seidu, MD, FRCP(Edin), FRCGP Recently, an international panel of experts developed objective practical recommendations on how continuous ketone monitoring could improve diabetes care. Even more recently, new data was presented on the prevalence, risk, burden, and management of DKA. Join worldwide experts as they discuss the practical application of all of...

Faculty: Mukul Sharma, MD, MSc, FRCPC Faculty: Ashkan Shoamanesh, MD, MSc, FRCPC Preventing stroke is critical, but for many patients, the fear of uncontrolled bleeding stands in the way of anticoagulation. What if we didn’t have to choose? Explore the emerging role of Factor XI/XIa inhibition and how it may redefine the balance between thrombosis and hemostasis. You’ll break down the science behi...

Faculty: David T. Rubin, MD Faculty: Ugonna Iroku, MD, MHS This program provides community gastroenterologists with a foundational overview of IBD, emphasizing how disease biology informs diagnosis, monitoring, and treatment selection. Faculty will cover the multifactorial drivers of disease, including genetic susceptibility, environmental exposures, the gut microbiome, and immune dysregulation. A...

Faculty: Michael Dolinger, MD, MBA This program provides community gastroenterologists with a foundational overview of IBD, emphasizing how disease biology informs diagnosis, monitoring, and treatment selection. Faculty will cover the multifactorial drivers of disease, including genetic susceptibility, environmental exposures, the gut microbiome, and immune dysregulation. A 3D animation illustrate...

Faculty: Florence Odufalu, MD This program provides community gastroenterologists with a foundational overview of IBD, emphasizing how disease biology informs diagnosis, monitoring, and treatment selection. Faculty will cover the multifactorial drivers of disease, including genetic susceptibility, environmental exposures, the gut microbiome, and immune dysregulation. A 3D animation illustrates the...

Faculty: Sharon Dudley-Brown, PhD, FNP-BC, FAAN, FAANP Faculty: Florence Odufalu, MD This program provides community gastroenterologists with a foundational overview of IBD, emphasizing how disease biology informs diagnosis, monitoring, and treatment selection. Faculty will cover the multifactorial drivers of disease, including genetic susceptibility, environmental exposures, the gut microbiome, a...

Faculty: David T. Rubin, MD Faculty: Michael Dolinger, MD, MBA This program provides community gastroenterologists with a foundational overview of IBD, emphasizing how disease biology informs diagnosis, monitoring, and treatment selection. Faculty will cover the multifactorial drivers of disease, including genetic susceptibility, environmental exposures, the gut microbiome, and immune dysregulatio...

Faculty: Florence-Damilola Odufalu, MD This program provides community gastroenterologists with a foundational overview of IBD, emphasizing how disease biology informs diagnosis, monitoring, and treatment selection. Faculty will cover the multifactorial drivers of disease, including genetic susceptibility, environmental exposures, the gut microbiome, and immune dysregulation. A 3D animation illust...

Faculty: David T. Rubin, MD Faculty: Ugonna Iroku, MD, MHS This program provides community gastroenterologists with a foundational overview of IBD, emphasizing how disease biology informs diagnosis, monitoring, and treatment selection. Faculty will cover the multifactorial drivers of disease, including genetic susceptibility, environmental exposures, the gut microbiome, and immune dysregulation. A...

Faculty: David T. Rubin, MD Faculty: Ugonna Iroku, MD, MHS This program provides community gastroenterologists with a foundational overview of IBD, emphasizing how disease biology informs diagnosis, monitoring, and treatment selection. Faculty will cover the multifactorial drivers of disease, including genetic susceptibility, environmental exposures, the gut microbiome, and immune dysregulation. A...

Faculty: Michael Dolinger, MD, MBA This program provides community gastroenterologists with a foundational overview of IBD, emphasizing how disease biology informs diagnosis, monitoring, and treatment selection. Faculty will cover the multifactorial drivers of disease, including genetic susceptibility, environmental exposures, the gut microbiome, and immune dysregulation. A 3D animation illustrate...

Faculty: Florence Odufalu, MD This program provides community gastroenterologists with a foundational overview of IBD, emphasizing how disease biology informs diagnosis, monitoring, and treatment selection. Faculty will cover the multifactorial drivers of disease, including genetic susceptibility, environmental exposures, the gut microbiome, and immune dysregulation. A 3D animation illustrates the...

Faculty: Sharon Dudley-Brown, PhD, FNP-BC, FAAN, FAANP Faculty: Florence Odufalu, MD This program provides community gastroenterologists with a foundational overview of IBD, emphasizing how disease biology informs diagnosis, monitoring, and treatment selection. Faculty will cover the multifactorial drivers of disease, including genetic susceptibility, environmental exposures, the gut microbiome, a...

Faculty: David T. Rubin, MD Faculty: Michael Dolinger, MD, MBA This program provides community gastroenterologists with a foundational overview of IBD, emphasizing how disease biology informs diagnosis, monitoring, and treatment selection. Faculty will cover the multifactorial drivers of disease, including genetic susceptibility, environmental exposures, the gut microbiome, and immune dysregulatio...

Faculty: Florence-Damilola Odufalu, MD This program provides community gastroenterologists with a foundational overview of IBD, emphasizing how disease biology informs diagnosis, monitoring, and treatment selection. Faculty will cover the multifactorial drivers of disease, including genetic susceptibility, environmental exposures, the gut microbiome, and immune dysregulation. A 3D animation illust...